Onsdag 12 Mars | 16:31:04 Europe / Stockholm

Kalender

Est. tid*
2026-02-25 08:20 Bokslutskommuniké 2025
2025-11-06 08:20 Kvartalsrapport 2025-Q3
2025-08-13 08:20 Kvartalsrapport 2025-Q2
2025-05-21 N/A X-dag ordinarie utdelning PMED 0.00 SEK
2025-05-20 N/A Årsstämma
2025-05-07 08:20 Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2025-01-07 - Extra Bolagsstämma 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-22 - X-dag ordinarie utdelning PMED 0.00 SEK
2024-05-21 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2024-01-11 - Extra Bolagsstämma 2023
2023-10-24 - Kvartalsrapport 2023-Q3
2023-08-11 - Kvartalsrapport 2023-Q2
2023-04-24 - Kvartalsrapport 2023-Q1
2023-04-21 - X-dag ordinarie utdelning PMED 0.00 SEK
2023-04-20 - Årsstämma
2023-02-24 - Bokslutskommuniké 2022
2023-01-09 - Extra Bolagsstämma 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning PMED 0.00 SEK
2022-05-24 - Årsstämma
2022-05-12 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-16 - Extra Bolagsstämma 2021
2021-11-10 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-06-10 - X-dag ordinarie utdelning PMED 0.00 SEK
2021-05-27 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-11-10 - Kvartalsrapport 2020-Q3
2020-08-17 - Kvartalsrapport 2020-Q2
2020-07-28 - Extra Bolagsstämma 2020
2020-06-30 - Årsstämma
2020-06-17 - X-dag ordinarie utdelning PMED 0.00 SEK
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-08 - Kvartalsrapport 2019-Q3
2019-08-16 - Kvartalsrapport 2019-Q2
2019-06-20 - X-dag ordinarie utdelning PMED 0.00 SEK
2019-06-19 - Årsstämma
2019-05-15 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-09 - Kvartalsrapport 2018-Q3
2018-08-17 - Kvartalsrapport 2018-Q2
2018-05-15 - Kvartalsrapport 2018-Q1
2018-03-29 - X-dag ordinarie utdelning PMED 0.00 SEK
2018-03-28 - Årsstämma
2018-02-27 - Bokslutskommuniké 2017
2017-11-09 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2
2017-05-19 - X-dag ordinarie utdelning PMED 0.00 SEK
2017-05-18 - Årsstämma
2017-05-16 - Kvartalsrapport 2017-Q1
2017-02-27 - Bokslutskommuniké 2016
2016-11-10 - Kvartalsrapport 2016-Q3
2016-08-17 - Kvartalsrapport 2016-Q2
2016-07-22 - Extra Bolagsstämma 2016
2016-05-20 - X-dag ordinarie utdelning PMED 0.00 SEK
2016-05-19 - Årsstämma
2016-05-17 - Kvartalsrapport 2016-Q1
2016-02-26 - Bokslutskommuniké 2015
2015-11-19 - Extra Bolagsstämma 2015
2015-11-11 - Kvartalsrapport 2015-Q3
2015-08-17 - Kvartalsrapport 2015-Q2
2015-05-08 - Kvartalsrapport 2015-Q1
2015-04-10 - X-dag ordinarie utdelning PMED 0.00 SEK
2015-04-09 - Årsstämma
2015-02-27 - Bokslutskommuniké 2014
2014-10-15 - Kvartalsrapport 2014-Q3
2014-08-13 - Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriBioteknik
Peptonic Medical är ett biomedicinskt bolag som bedriver forskning kring och utveckling av läkemedel och medicintekniska produkter inom området kvinnohälsa. Bolagets vision är att erbjuda behandlingar för kvinnospecifika sjukdomar och medicinska tillstånd. Exempelvis sker utveckling av hormonfria produkter för behandling av vaginal atrofi och vaginal torrhet. Bolaget har sitt huvudkontor i Bromma.
2025-02-20 08:00:00

Peptonic Medical AB (publ) ("Peptonic" or "the Company") is thrilled to announce the highly anticipated U.S. launch of its portfolio of intimate care products under the VagiVital brand. Backed by a thorough competitive audit and extensive market preparation the launch kicks off with VagiVital Moisturizing Intimate V Cleanser, targeting millennials and Gen Z through strategic social media campaigns on TikTok, Instagram, YouTube, and Facebook. With a science-backed portfolio of intimate self-care products and a steadfast commitment to empowering conversations around vaginal health, Peptonic aims to redefine intimate wellness for women nationwide with its innovative solutions

To support the full-scale launch of its products to the U.S. market, Peptonic has partnered with the Los Angeles-based agency 1DS Collective to lead the efforts. After a brief delay, Peptonic is now rolling out campaigns to market VagiVital products, challenge outdated stigmas, and empower women to embrace intimate health. By placing science-backed intimate selfcare at the forefront, Peptonic aims to redefine the category with a fresh and engaging approach. The rollout begins with the VagiVital Moisturizing Intimate V Cleanser, followed by the complete product lineup, including VagiVital Intimate Calming Gel, VagiVital AktivGel, Vernivia, and VagiVital Active Glide.

A comprehensive content strategy will establish a dynamic and visually captivating presence for VagiVital. The rollout includes professional lifestyle photography, video, 3D animations showcasing the brand's Swedish heritage and science narratives, user-generated content, and engaging commercials to run on the Google Ad Network (including YouTube) and the Meta Ad Network (Facebook and Instagram). In addition, influencer partnerships will amplify the campaign by sharing authentic, relatable stories that resonate with women of all ages. These efforts aim to spark meaningful conversations, build trust, and inspire women to take control of their intimate health with VagiVital.

All VagiVital products will be available for purchase on Amazon and through the company's web shop.

The U.S. launch marks a significant milestone for Peptonic, now, more than ever, we're ready to bring our science-backed intimate selfcare products to women across the U.S. and spark the candid conversations that intimate care so desperately needs. We look forward to the exciting opportunities as we are in the beginning of our full scale rollout in the U.S." says Anna Linton, CEO."

For further information, please contact:
Anna Linton, CEO, Peptonic Medical AB                                                                                                             
Email:
anna.linton@peptonicmedical.se                                                                                                                                
Phone: +46 70-244 92 07

About Peptonic Medical AB                                                                                                         
PEPTONIC medical AB (publ) is a pioneering Swedish medtech company specializing in the development and sale of clinically proven self-care products for women's intimate health. Through its brands VagiVital and Vernivia, the Company offers a broad over-the-counter portfolio of effective and gentle products designed to help women understand, treat, and prevent common medical conditions in the intimate area. Peptonic's growth strategy centers on geographic expansion, particularly in the U.S. and Europe, while continually enhancing its product portfolio through in-house development and strategic acquisitions.

The Company is headquartered in Stockholm, Sweden, and operates a subsidiary, Common Sense Marketing Inc., in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.